ATRS
Antares Pharma, Inc.
ATRS
ATRS
Delisted
ATRS was delisted on the 23rd of May, 2022.
83 hedge funds and large institutions have $57.2M invested in Antares Pharma, Inc. in 2016 Q1 according to their latest regulatory filings, with 11 funds opening new positions, 30 increasing their positions, 22 reducing their positions, and 16 closing their positions.
Holders
83
Holders Change
-5
Holders Change %
-5.68%
% of All Funds
2.22%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
11
Increased
30
Reduced
22
Closed
16
Calls
$44K
Puts
–
Net Calls
+$44K
Net Calls Change
-$52K
Top Buyers
1 |
BC
1
Broadfin Capital
New York
|
$13.1M |
2 |
2
Morgan Stanley
New York
|
$2.3M |
3 |
AC
3
Armistice Capital
New York
|
$13.4M |
4 |
4
Renaissance Technologies
New York
|
$1.94M |
5 |
PAM
5
Panagora Asset Management
Boston,
Massachusetts
|
$1.43M |